These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Determination of the epinephrine-refractory hypoglycaemic activity of whole-cell pertussis vaccine in mice. Horiuchi Y; Iida T J Biol Stand; 1988 Oct; 16(4):239-48. PubMed ID: 3143732 [TBL] [Abstract][Full Text] [Related]
23. [Determination of the toxicity of whooping cough vaccines to chick embryos]. Fedoseeva TM Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):16-21. PubMed ID: 5614278 [No Abstract] [Full Text] [Related]
24. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526 [TBL] [Abstract][Full Text] [Related]
25. [Vaccine combinations: vaccines against diphtheria, tetanus, pertussis and poliomyelitis]. Gateff C Soins Pathol Trop; 1984; (47):29-30. PubMed ID: 6567282 [No Abstract] [Full Text] [Related]
26. [Local reactions following booster injections with DWTP-vaccine (diphtheria-whooping cough-tetanus-poliovirus vaccine) in children born in 1960 and 1961]. Swaak AJ Ned Tijdschr Geneeskd; 1966 Feb; 110(7):332-4. PubMed ID: 5907700 [No Abstract] [Full Text] [Related]
27. Swelling of the brain in mice caused by pertussis vaccine--its quantitative determination and the responsible factors in the vaccine. Iwasa S; Ishida S; Akama K Jpn J Med Sci Biol; 1985 Apr; 38(2):53-65. PubMed ID: 3878421 [TBL] [Abstract][Full Text] [Related]
28. [A severe adverse event after vaccine for diphtheria, tetanus, pertussis and poliomyelitis (DTP + polio) in a 4.5 month old infant]. Wierzba J; Irga N; Balcerska A; Borzych D Przegl Lek; 2000; 57(7-8):436-8. PubMed ID: 11109323 [TBL] [Abstract][Full Text] [Related]
29. [Study of the reactogenic and allergic properties of vaccines with pertussin xomponents in experiments and epidemiologic trial]. Klimovitskaia VE; Baeva EA; Leĭtes FL; Bolotovskiĭ VM Zh Mikrobiol Epidemiol Immunobiol; 1967 Jan; 44(1):145-8. PubMed ID: 5613969 [No Abstract] [Full Text] [Related]
30. Toxicity and toxicity testing of pertussis vaccine. Kurokawa M Jpn J Med Sci Biol; 1984 Apr; 37(2):41-81. PubMed ID: 6207324 [No Abstract] [Full Text] [Related]
31. Clinical trial of concentrated inactivated polio vaccine in a simplified immunization program. Fillastre C; Emmou C; Meyran M; Schlumberger M; Guérin N Dev Biol Stand; 1981; 47():207-13. PubMed ID: 6262148 [TBL] [Abstract][Full Text] [Related]
32. [Vaccination: principles and practice in 1980. Review and concepts. I. Historical development, adverse effects, diphtheria, tetanus, and whooping cough, poliomyelitis, and measles]. Ramírez Ronda CH; Bermúdez RH; Pérez Pabón MJ; Quiñones-Soto RA Bol Asoc Med P R; 1980 Jul; 72(7):339-52. PubMed ID: 7000091 [No Abstract] [Full Text] [Related]
33. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of the toxic effects of preventive and therapeutic preparations in transplantable cell cultures from different species and of different origins. I. Demonstration of the toxic properties of commercial batches of adsorbed DPT vaccine in cell cultures]. Sovetova GP; Chebotareva SV; Amchenkova AM; Davydova AV; Rovenskiĭ IuA Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):84-7. PubMed ID: 6800166 [TBL] [Abstract][Full Text] [Related]
35. [Advantages of using pharmacologic tests to characterize bacterial vaccines]. Koval'skaia SIa; Ozeretskovskiĭ NA; Veĭsfeĭler OIu; Bulatova AI Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):54-8. PubMed ID: 7192038 [TBL] [Abstract][Full Text] [Related]
36. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA; King J; Law B; Mills E; Willems P Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624 [TBL] [Abstract][Full Text] [Related]
37. [Organization of prophylactic vaccination of children in general practice]. Schmidt HW Landarzt; 1965 Oct; 41(29):1261-2. PubMed ID: 5880742 [No Abstract] [Full Text] [Related]
38. [IPAD-DTCP: study of the tolerability and serum antipoliomyelitic efficacy in a maternal-child health center at Pikine (Dakar)]. Loucq C; Yvonnet B; Jeannee E; Marie FN; Chabanier G Med Trop (Mars); 1984; 44(1):65-7. PubMed ID: 6330491 [TBL] [Abstract][Full Text] [Related]
39. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy. Brock B; Mckee B Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210 [No Abstract] [Full Text] [Related]